Erschienen in:

01.01.2018 | Clinical study

CVD prevalence low in patients receiving ADHD medication

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Auszug

The prevalence of cardiovascular disorder (CVD) is generally low in patients receiving attention-deficit hyperactivity disorder (ADHD) medication,¹ but increases with age, according to findings of a US study published in Drugs - Real World Outcomes. …

amphetamines, atomoxetine, dexmethylphenidate or methylphenidate

Fairman KA, et al. Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? Drugs - Real World Outcomes : 5 Jan 2018. Available from: URL: https://doi.org/10.1007/s40801-017-0129-2

Titel: CVD prevalence low in patients receiving ADHD medication
Publikationsdatum: 01.01.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-41074-6

Springer Medizin

CVD prevalence low in patients receiving ADHD medication

Auszug

Weitere Artikel der Ausgabe 1/2018

Hydrocortisone butyrate

Bucillamine/methotrexate

Methylprednisolone

Immune globulin

Amiodarone

Prednisone

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Hydrocortisone butyrate

Bucillamine/methotrexate

Methylprednisolone

Immune globulin

Amiodarone

Prednisone